AU7513291A - Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use - Google Patents
Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological useInfo
- Publication number
- AU7513291A AU7513291A AU75132/91A AU7513291A AU7513291A AU 7513291 A AU7513291 A AU 7513291A AU 75132/91 A AU75132/91 A AU 75132/91A AU 7513291 A AU7513291 A AU 7513291A AU 7513291 A AU7513291 A AU 7513291A
- Authority
- AU
- Australia
- Prior art keywords
- hexetidine
- salts
- preparation
- pharmaceutical composition
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to the use of hexetidine or its non-toxic derivatives or salts, with the use envisaged for the preparation of a pharmaceutical composition having ophthalmic antiseptic activity, making possible, in particular, the therapeutic treatment of connective tissues in the absence or presence of ophthalmic prostheses, and in particular contact lenses. Application: ophthalmology.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR909004945A FR2661091B1 (en) | 1990-04-18 | 1990-04-18 | USE OF HEXETIDINE OR ITS DERIVATIVES OR SALTS FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR OPHTHALMOLOGICAL USE. |
FR9004945 | 1990-04-18 |
Publications (2)
Publication Number | Publication Date |
---|---|
AU7513291A true AU7513291A (en) | 1991-10-24 |
AU643772B2 AU643772B2 (en) | 1993-11-25 |
Family
ID=9395848
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU75132/91A Ceased AU643772B2 (en) | 1990-04-18 | 1991-04-17 | Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP0453337B1 (en) |
JP (1) | JPH04234818A (en) |
AT (1) | ATE158719T1 (en) |
AU (1) | AU643772B2 (en) |
BR (1) | BR9101544A (en) |
CA (1) | CA2039566A1 (en) |
DE (1) | DE69127767T2 (en) |
DK (1) | DK0453337T3 (en) |
ES (1) | ES2109937T3 (en) |
FR (1) | FR2661091B1 (en) |
HU (1) | HUT57985A (en) |
MC (1) | MC2217A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1992009283A1 (en) * | 1990-11-26 | 1992-06-11 | Warner-Lambert Company | Stabilized hexahydro-5-pyrimidinamine compounds in aqueous solution and methods for preparing same |
DE10147186A1 (en) * | 2001-09-25 | 2003-04-24 | Beiersdorf Ag | Synergistic antimicrobial composition, useful e.g. as cosmetic preservative and for treating skin disorders, comprises polyhexamethylene biguanide and distearyldimethylammonium chloride |
US9737609B2 (en) * | 2014-08-20 | 2017-08-22 | Professional Compounding Centers Of America (Pcca) | Natural suspending agent including a synergistic blend of xanthan gum and konjac powder for oral pharmaceutical suspensions |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
NL89993C (en) * | 1954-08-02 | |||
FR2552305B1 (en) * | 1983-09-22 | 1985-12-20 | Salkin Andre | HIGH BACTERICIDAL COMPOSITION CONTAINING BIGUANIDE AND PYRIMIDINE |
EP0215136B1 (en) * | 1985-09-02 | 1988-06-22 | Artesan Pharma Gesellschaft mit beschränkter Haftung | Hexetidin-containing therapeutically active agent, method for its preparation and its use as a vaginal disinfectant |
US4666517A (en) * | 1986-06-04 | 1987-05-19 | Colgate-Palmolive Co. | Antiplaque oral composition |
-
1990
- 1990-04-18 FR FR909004945A patent/FR2661091B1/en not_active Expired - Fee Related
-
1991
- 1991-03-20 DE DE69127767T patent/DE69127767T2/en not_active Expired - Fee Related
- 1991-03-20 AT AT91400743T patent/ATE158719T1/en not_active IP Right Cessation
- 1991-03-20 DK DK91400743.0T patent/DK0453337T3/en active
- 1991-03-20 ES ES91400743T patent/ES2109937T3/en not_active Expired - Lifetime
- 1991-03-20 EP EP91400743A patent/EP0453337B1/en not_active Expired - Lifetime
- 1991-03-22 MC MC912178A patent/MC2217A1/en unknown
- 1991-04-02 CA CA002039566A patent/CA2039566A1/en not_active Abandoned
- 1991-04-17 BR BR919101544A patent/BR9101544A/en not_active Application Discontinuation
- 1991-04-17 JP JP3112393A patent/JPH04234818A/en active Pending
- 1991-04-17 AU AU75132/91A patent/AU643772B2/en not_active Ceased
- 1991-04-18 HU HU911272A patent/HUT57985A/en unknown
Also Published As
Publication number | Publication date |
---|---|
HU911272D0 (en) | 1991-10-28 |
ES2109937T3 (en) | 1998-02-01 |
EP0453337A2 (en) | 1991-10-23 |
HUT57985A (en) | 1992-01-28 |
MC2217A1 (en) | 1993-02-02 |
EP0453337A3 (en) | 1992-11-25 |
CA2039566A1 (en) | 1991-10-19 |
JPH04234818A (en) | 1992-08-24 |
EP0453337B1 (en) | 1997-10-01 |
DE69127767D1 (en) | 1997-11-06 |
FR2661091A1 (en) | 1991-10-25 |
DE69127767T2 (en) | 1998-04-30 |
DK0453337T3 (en) | 1998-05-18 |
AU643772B2 (en) | 1993-11-25 |
BR9101544A (en) | 1991-12-10 |
ATE158719T1 (en) | 1997-10-15 |
FR2661091B1 (en) | 1994-10-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1225168B8 (en) | Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension | |
AU7182296A (en) | Terfenadine metabolites and their optically pure isomers for treating allergic disorders | |
EE02971B1 (en) | Use of droloxyfene or its salts in the manufacture of a medicament for the treatment of bone diseases | |
PT88985A (en) | Process for the preparation of nasal and ophthalmic pharmaceutical compositions containing azelastine | |
IE811654L (en) | Ophthalmic composition | |
NO975962D0 (en) | Drug preparation comprising albumin as active ingredient | |
GR3006815T3 (en) | ||
DK0668077T3 (en) | Products containing G-CSF and TNF-binding protein | |
EP0403360A3 (en) | Use of phenylethanolamines for the preparation of a medicament for treating ophthalmologic disorders | |
ZA991749B (en) | Pharmaceutical composition for prophylaxis and therapy of diseases associated with ocular fundus tissue cytopathy. | |
AU1458495A (en) | Application of riluzole in the treatment of mitochondrial diseases | |
AU643772B2 (en) | Use of hexetidine or its derivatives or salts for the preparation of a pharmaceutical composition for ophthalmological use | |
DK0410749T3 (en) | Anthocyanidins for the treatment of ophthalmic diseases | |
DE3273950D1 (en) | Use of 1-(p-isopropoxyethoxymethyl-phenoxy)-3-isopropylaminopropan-2-ol for the preparation of a medicament for the reduction of internal pressure in the eye | |
EP0345028A3 (en) | Treatment of glaucoma using phosphodiesterase inhibitor | |
DE69100171D1 (en) | SYNERGISTIC COMBINATION FOR OPHTHALMIC USE. | |
AU2129200A (en) | Use of nerve growth factor for therapy of intraocular tissue pathologies | |
AU1217392A (en) | Corneal treatment agents | |
AU1706392A (en) | The use of 1-(5-oxohexyl)-3-methyl-7-n-propylxanthine in vascular surgery | |
PT97878A (en) | Process for the preparation of a pharmaceutical composition for ophthalmic use containing hexetidine or derivatives or salts thereof | |
RU93015155A (en) | MEDICINE FOR THE TREATMENT OF DYSTROPHIC DISEASES AND INJURIES OF THE EYE TISSUES | |
GR3018349T3 (en) | Use of naproxen as mydriatic agent. | |
BG96092A (en) | THIENOTHIOPYRAN SULFONAMIDE DERIVATIVES AND THEIR APPLICATION IN OPHTHALMOLOGICAL PREPARATIONS | |
RU93021719A (en) | METHOD OF TREATMENT OF THE RETINA | |
UA19587A (en) | Method for surgical elimination of traumatic iridodialysis in patients with post-traumatic corneal caligo |